198 related articles for article (PubMed ID: 23100452)
1. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.
Di Pasqua AJ; Yuan H; Chung Y; Kim JK; Huckle JE; Li C; Sadgrove M; Tran TH; Jay M; Lu X
J Nucl Med; 2013 Jan; 54(1):111-6. PubMed ID: 23100452
[TBL] [Abstract][Full Text] [Related]
2. Preparation of neutron-activatable holmium nanoparticles for the treatment of ovarian cancer metastases.
Di Pasqua AJ; Huckle JE; Kim JK; Chung Y; Wang AZ; Jay M; Lu X
Small; 2012 Apr; 8(7):997-1000. PubMed ID: 22298503
[TBL] [Abstract][Full Text] [Related]
3. Neutron-Activatable Nanoparticles for Intraperitoneal Radiation Therapy.
Hargrove D; Lu X
Methods Mol Biol; 2017; 1530():379-389. PubMed ID: 28150216
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
5. Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres.
Nijsen JF; van Het Schip AD; van Steenbergen MJ; Zielhuis SW; Kroon-Batenburg LM; van de Weert M; van Rijk PP; Hennink WE
Biomaterials; 2002 Apr; 23(8):1831-9. PubMed ID: 11950053
[TBL] [Abstract][Full Text] [Related]
6. Microbrachytherapy using holmium-166 acetylacetonate microspheres: a pilot study in a spontaneous cancer animal model.
Bult W; Vente MA; Vandermeulen E; Gielen I; Seevinck PR; Saunders J; van Het Schip AD; Bakker CJ; Krijger GC; Peremans K; Nijsen JF
Brachytherapy; 2013; 12(2):171-7. PubMed ID: 22999975
[TBL] [Abstract][Full Text] [Related]
7. Holmium-loaded PLLA nanoparticles for intratumoral radiotherapy via the TMT technique: preparation, characterization, and stability evaluation after neutron irradiation.
Hamoudeh M; Fessi H; Salim H; Barbos D
Drug Dev Ind Pharm; 2008 Aug; 34(8):796-806. PubMed ID: 18651284
[TBL] [Abstract][Full Text] [Related]
8. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapeutic bandage based on electrospun polyacrylonitrile containing holmium-166 iron garnet nanoparticles for the treatment of skin cancer.
Munaweera I; Levesque-Bishop D; Shi Y; Di Pasqua AJ; Balkus KJ
ACS Appl Mater Interfaces; 2014 Dec; 6(24):22250-6. PubMed ID: 25396281
[TBL] [Abstract][Full Text] [Related]
10. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
[TBL] [Abstract][Full Text] [Related]
11. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
12. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
He Q; Zhang Z; Gao F; Li Y; Shi J
Small; 2011 Jan; 7(2):271-80. PubMed ID: 21213393
[TBL] [Abstract][Full Text] [Related]
13. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
14. Facile incorporation of aggregation-induced emission materials into mesoporous silica nanoparticles for intracellular imaging and cancer therapy.
Zhang X; Zhang X; Wang S; Liu M; Zhang Y; Tao L; Wei Y
ACS Appl Mater Interfaces; 2013 Mar; 5(6):1943-7. PubMed ID: 23363527
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
17. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
[TBL] [Abstract][Full Text] [Related]
18. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
19. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional mesoporous silica nanoparticles as cooperative catalysts for the Tsuji-Trost reaction--tuning the reactivity of silica nanoparticles.
Dickschat AT; Behrends F; Surmiak S; Weiss M; Eckert H; Studer A
Chem Commun (Camb); 2013 Mar; 49(22):2195-7. PubMed ID: 23392252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
